flow trial semaglutide kidney outcomes hazard ratio 0.76 2024 nejm Study: Semaglutide slowed progression of CKD, cut cardiovascular events, mortality risk 🚨 Journal Club: FLOW Trial – Post hoc analysis of SUSTAIN

To learn more about semaglutide or tirzepatide, use the button below.

Be ready to declare it at airport security with its original packaging and your prescription

Data indicates that patients taking 0.5 mg of Ozempic per week are more likely to experience acid reflux and heartburn

If that's not enough, ULTRA BURN is a terrific method to obtain your daily amount of chromium while simultaneously promoting fat reduction and maintaining muscle mass

10.1161/CIRCRESAHA.115.306656 41

Get the nutrition wrong and you lose muscle instead of fat, develop deficiencies that cause fatigue and hair loss, or trigger gastrointestinal side effects so severe you want to quit the medication entirely